NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)

Clinical trial NCT06079333 · RECRUITING

Trial details

NCT number: NCT06079333
Sponsor: Leiden University Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Thyroid Cancer

Start date: 2023-01-01
Primary completion: 2027-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.